Mutations in the gene for the IL-7 receptor result in T-B+NK+ severe combined immunodeficiency disease

Current Opinion in Immunology

Volumn 12, Issue 4, 2000, Pages 468-473

  Puel, Anne ^a   Leonard, Warren J ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 7; INTERLEUKIN 7 RECEPTOR; JANUS KINASE;

B LYMPHOCYTE; COMBINED IMMUNODEFICIENCY; GENE MUTATION; HUMAN; IMMUNOGENETICS; NATURAL KILLER CELL; NONHUMAN; RECEPTOR GENE; REVIEW; T LYMPHOCYTE; X CHROMOSOME LINKAGE;

EID: 0034124136     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(00)00122-9     Document Type: Review

References (72)

1. Buckley R.H., Schiff R.I., Schiff S.E., Markert M.L., Williams L.W., Harville T.O., Roberts J.L., Puck J.M. Human severe combined immunodeficiency: genetic, phenotypic, and functional diversity in one hundred eight infants. J Pediatr. 130:1997;378-387.
2. Buckley R.H., Schiff S.E., Schiff R.I., Markert L., Williams L.W., Roberts J.L., Myers L.A., Ward F.E. Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency. N Engl J Med. 340:1999;508-516.
3. Fischer A., Cavazzana-Calvo M., De Saint Basile G., DeVillartay J.P., Di Santo J.P., Hivroz C., Rieux-Laucat F., Le Deist F. Naturally occurring primary deficiencies of the immune system. Annu Rev Immunol. 15:1997;93-124.
4. + severe combined immunodeficiencies in humans. Roifman C. Immunology and Allergy Clinics of North America, vol 20. 2000;51-64 WB Saunders Company, Philadelphia. This report, along with [30], provides evidence for the critical role of IL-7/IL-7R signaling in T cell development in humans and that the T cell defect observed in XSCID and Jak3-deficient SCID patients can largely, if not entirely, be attributed to defective IL-7 signaling.
5. Leonard W.J. The molecular basis of X-linked severe combined immunodeficiency: defective cytokine receptor signalling. Annu Rev Med. 47:1996;229-239.
6. de Saint Basile G., Arveiler B., Oberle I., Malcolm S., Levinsky R.J., Lau Y.L., Hofker M., Debre M., Fischer A., Griscelli C.et al. Close linkage of the locus for X chromosome-linked severe combined immunodeficiency to polymorphic DNA markers in Xq11-q13. Proc Natl Acad Sci USA. 84:1987;7576-7579.
7. Takeshita T., Asao H., Ohtani K., Ishii N., Kumaki S., Tanaka N., Munakata H., Nakamura M., Sugamura K. Cloning of the γ chain of the human IL-2 receptor. Science. 257:1992;379-382.
8. Noguchi M., Yi H., Rosenblatt H.M., Filipovich A.H., Adelstein S., Modi W.S., McBride O.W., Leonard W.J. Interleukin-2 receptor γ chain mutation results in X-linked severe combined immunodeficiency in humans. Cell. 73:1993;147-157.
9. c-dependent cytokines regulate T-cell development. Immunol Today. 20:1999;71-76.
10. Baird A.M., Gerstein R.M., Berg L.J. The role of cytokine receptor signaling in lymphocyte development. Curr Opin Immunol. 11:1999;157-166.
11. c chains with Jak1 and Jak3: implications for XSCID and XCID. Science. 266:1994;1042-1045.
12. Leonard W.J., O'Shea J.J. Jaks and STATs: biological implications. Annu Rev Immunol. 16:1998;293-322.
13. Russell S.M., Tayebi N., Nakajima H., Riedy M.C., Roberts J.L., Aman M.J., Migone T.S., Noguchi M., Markert M.L., Buckley R.H.et al. Mutation of Jak3 in a patient with SCID: essential role of Jak3 in lymphoid development. Science. 270:1995;797-800.
14. Macchi P., Villa A., Gillani S., Sacco M.G., Frattini A., Porta F., Ugazio A.G., Johnston J.A., Candotti F., O'Shea J.J.et al. Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID). Nature. 377:1995;65-68.
15. Waldmann T.A., Tagaya Y. The multifaceted regulation of interleukin-15 expression and the role of this cytokine in NK cell differentiation and host response to intracellular pathogens. Annu Rev Immunol. 17:1999;19-49.
16. De Smedt M., Verhasselt B., Kerre T., Vanhecke D., Naessens E., Leclercq G., Renauld J.C., Van Snick J., Plum J. Signals from the IL-9 receptor are critical for the early stages of human intrathymic T cell development. J Immunol. 164:2000;1761-1767.
17. von Freeden-Jeffry U., Vieira P., Lucian L.A., McNeil T., Burdach S.E., Murray R. Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine. J Exp Med. 181:1995;1519-1526.
18. Peschon J.J., Morrissey P.J., Grabstein K.H., Ramsdell F.J., Maraskovsky E., Gliniak B.C., Park L.S., Ziegler S.F., Williams D.E., Ware C.B.et al. Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice. J Exp Med. 180:1994;1955-1960.
19. Grabstein K.H., Waldschmidt T.J., Finkelman F.D., Hess B.W., Alpert A.R., Boiani N.E., Namen A.E., Morrissey P.J. Inhibition of murine B and T lymphopoiesis in vivo by an anti-interleukin 7 monoclonal antibody. J Exp Med. 178:1993;257-264.
20. -/- mice. J Immunol. 157:1996;2366-2373.
21. + T cells, but not natural killer cells. J Exp Med. 184:1996;289-293.
22. Cao X., Shores E.W., Hu-Li J., Anver M.R., Kelsall B.L., Russell S.M., Drago J., Noguchi M., Grinberg A., Bloom E.T.et al. Defective lymphoid development in mice lacking expression of the common cytokine receptor γ chain. Immunity. 2:1995;223-238.
23. DiSanto J.P., Muller W., Guy-Grand D., Fischer A., Rajewsky K. Lymphoid development in mice with a targeted deletion of the interleukin 2 receptor γ chain. Proc Natl Acad Sci USA. 92:1995;377-381.
24. Nosaka T., van Deursen J.M., Tripp R.A., Thierfelder W.E., Witthuhn B.A., McMickle A.P., Doherty P.C., Grosveld G.C., Ihle J.N. Defective lymphoid development in mice lacking Jak3. Science. 270:1995;800-802.
25. Thomis D.C., Gurniak C.B., Tivol E., Sharpe A.H., Berg L.J. Defects in B lymphocyte maturation and T lymphocyte activation in mice lacking Jak3. Science. 270:1995;794-797.
26. Maraskovsky E., Teepe M., Morrissey P.J., Braddy S., Miller R.E., Lynch D.H., Peschon J.J. Impaired survival and proliferation in IL-7 receptor-deficient peripheral T cells. J Immunol. 157:1996;5315-5323.
27. Ray R.J., Furlonger C., Williams D.E., Paige C.J. Characterization of thymic stromal-derived lymphopoietin (TSLP) in murine B cell development in vitro. Eur J Immunol. 26:1996;10-16.
28. Levin S.D., Koelling R.M., Friend S.L., Isaksen D.E., Ziegler S.F., Perlmutter R.M., Farr A.G. Thymic stromal lymphopoietin: a cytokine that promotes the development of IgM+ B cells in vitro and signals via a novel mechanism. J Immunol. 162:1999;677-683.
29. Isaksen D.E., Baumann H., Trobridge P.A., Farr A.G., Levin S.D., Ziegler S.F. Requirement for Stat5 in thymic stromal lymphopoietin-mediated signal transduction. J Immunol. 163:1999;5971-5977.
30. + severe combined immunodeficiency. Nat Genet. 20:1998;394-397.
31. Kumaki S., Ishii N., Minegishi M., Tsuchiya S., Cosman D., Sugamura K., Konno T. Functional role of interleukin-4 (IL-4) and IL-7 in the development of X-linked severe combined immunodeficiency. Blood. 93:1999;607-612.
32. Watanabe M., Ueno Y., Yajima T., Iwao Y., Tsuchiya M., Ishikawa H., Aiso S., Hibi T., Ishii H. Interleukin 7 is produced by human intestinal epithelial cells and regulates the proliferation of intestinal mucosal lymphocytes. J Clin Invest. 95:1995;2945-2953.
33. Laky K., Lefrancois L., von Freeden-Jeffry U., Murray R., Puddington L. The role of IL-7 in thymic and extrathymic development of TCR γδ cells. J Immunol. 161:1998;707-713.
34. Maeurer M.J., Lotze M.T. Interleukin-7 (IL-7) knockout mice. Implications for lymphopoiesis and organ-specific immunity. Int Rev Immunol. 16:1998;309-322.
35. Hofmeister R., Khaled A.R., Benbernou N., Rajnavolgyi E., Muegge K., Durum S.K. Interleukin-7: physiological roles and mechanisms of action. Cytokine Growth Factor Rev. 10:1999;41-60. A comprehensive review of IL-7 and the IL-7 receptor.
36. Appasamy P.M. Biological and clinical implications of interleukin-7 and lymphopoiesis. Cytokines Cell Mol Ther. 5:1999;25-39.
37. Foxwell B.M., Beadling C., Guschin D., Kerr I., Cantrell D. Interleukin-7 can induce the activation of Jak 1, Jak 3 and STAT 5 proteins in murine T cells. Eur J Immunol. 25:1995;3041-3046.
38. Zeng Y.X., Takahashi H., Shibata M., Hirokawa K. JAK3 Janus kinase is involved in interleukin 7 signal pathway. FEBS Lett. 353:1994;289-293.
39. c chain of the IL-2 receptor. Science. 266:1994;1039-1042.
40. Miyazaki T., Kawahara A., Fujii H., Nakagawa Y., Minami Y., Liu Z.J., Oishi I., Silvennoinen O., Witthuhn B.A., Ihle J.N.et al. Functional activation of Jak1 and Jak3 by selective association with IL-2 receptor subunits. Science. 266:1994;1045-1047.
41. Rodig S.J., Meraz M.A., White J.M., Lampe P.A., Riley J.K., Arthur C.D., King K.L., Sheehan K.C., Yin L., Pennica D.et al. Disruption of the Jak1 gene demonstrates obligatory and nonredundant roles of the Jaks in cytokine-induced biologic responses. Cell. 93:1998;373-383.
42. Nakajima H., Liu X., Wynshaw-Boris A., Rosenthal L.A., Imada K., Finbloom D.S., Hennighausen L., Leonard W.J. An indirect effect of Stat5a in IL-2-induced proliferation: a critical role for Stat5a in IL-2-mediated IL-2 receptor α chain induction. Immunity. 7:1997;691-701.
43. Imada K., Bloom E.T., Nakajima H., Horvath-Arcidiacono J.A., Udy G.B., Davey H.W., Leonard W.J. Stat5b is essential for natural killer cell-mediated proliferation and cytolytic activity. J Exp Med. 188:1998;2067-2074.
44. Moriggl R., Topham D.J., Teglund S., Sexl V., McKay C., Wang D., Hoffmeyer A., van Deursen J., Sangster M.Y., Bunting K.D.et al. Stat5 is required for IL-2-induced cell cycle progression of peripheral T cells. Immunity. 10:1999;249-259.
45. Pallard C., Stegmann A.P., van Kleffens T., Smart F., Venkitaraman A., Spits H. Distinct roles of the phosphatidylinositol 3-kinase and STAT5 pathways in IL-7-mediated development of human thymocyte precursors. Immunity. 10:1999;525-535.
46. Kagami S., Nakajima H., Kumano K., Suzuki K., Suto A., Imada K., Davey H.W., Saito Y., Takatsu K., Leonard W.J., Iwamoto I. Both Stat5a and Stat5b are required for antigen-induced eosinophil and T-cell recruitment into the tissue. Blood. 95:2000;1370-1377.
47. Venkitaraman A.R., Cowling R.J. Interleukin-7 induces the association of phosphatidylinositol 3-kinase with the α chain of the interleukin-7 receptor. Eur J Immunol. 24:1994;2168-2174.
48. Lin J.X., Migone T.S., Tsang M., Friedmann M., Weatherbee J.A., Zhou L., Yamauchi A., Bloom E.T., Mietz J., John S.et al. The role of shared receptor motifs and common Stat proteins in the generation of cytokine pleiotropy and redundancy by IL-2, IL-4, IL-7, IL-13, and IL-15. Immunity. 2:1995;331-339.
49. Fruman D.A., Snapper S.B., Yballe C.M., Davidson L., Yu J.Y., Alt F.W., Cantley L.C. Impaired B cell development and proliferation in absence of phosphoinositide 3-kinase p85α Science. 283:1999;393-397.
50. Suzuki H., Terauchi Y., Fujiwara M., Aizawa S., Yazaki Y., Kadowaki T., Koyasu S. Xid-like immunodeficiency in mice with disruption of the p85α subunit of phosphoinositide 3-kinase. Science. 283:1999;390-392.
51. Sharfe N., Roifman C.M. Differential association of phosphatidylinositol 3-kinase with insulin receptor substrate (IRS)-1 and IRS-2 in human thymocytes in response to IL-7. J Immunol. 159:1997;1107-1114.
52. fyn through a segment of its cytoplasmic tail. Proc Natl Acad Sci USA. 89:1992;2083-2087.
53. fyn, two tyrosine kinases associated with the p90 interleukin-7 receptor in primary human T cells. Eur J Immunol. 25:1995;2956-2960.
54. Takeshita T., Arita T., Higuchi M., Asao H., Endo K., Kuroda H., Tanaka N., Murata K., Ishii N., Sugamura K. STAM, signal transducing adaptor molecule, is associated with Janus kinases and involved in signaling for cell growth and c-myc induction. Immunity. 6:1997;449-457.
55. Crawley J.B., Rawlinson L., Lali F.V., Page T.H., Saklatvala J., Foxwell B.M. T cell proliferation in response to interleukins 2 and 7 requires p38MAP kinase activation. J Biol Chem. 272:1997;15023-15027.
56. Jacobs H., Krimpenfort P., Haks M., Allen J., Blom B., Demolliere C., Kruisbeek A., Spits H., Berns A. PIM1 reconstitutes thymus cellularity in interleukin 7- and common γ chain-mutant mice and permits thymocyte maturation in Rag- but not CD3 γ-deficient mice. J Exp Med. 190:1999;1059-1068.
57. von Freeden-Jeffry U., Solvason N., Howard M., Murray R. The earliest T lineage-committed cells depend on IL-7 for Bcl-2 expression and normal cell cycle progression. Immunity. 7:1997;147-154.
58. Amos C.L., Woetmann A., Nielsen M., Geisler C., Odum N., Brown B.L., Dobson P.R. The role of caspase 3 and BclxL in the action of interleukin 7 (IL-7): a survival factor in activated human T cells. Cytokine. 10:1998;662-668.
59. Strasser A., Harris A.W., Cory S. bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship. Cell. 67:1991;880-889.
60. Akashi K., Kondo M., von Freeden-Jeffry U., Murray R., Weissman I.L. Bcl-2 rescues T lymphopoiesis in interleukin-7 receptor-deficient mice. Cell. 89:1997;1033-1041.
61. Kondo M., Akashi K., Domen J., Sugamura K., Weissman I.L. Bcl-2 rescues T lymphopoiesis, but not B or NK cell development, in common γ chain-deficient mice. Immunity. 7:1997;155-162.
62. Nakajima H., Leonard W.J. Role of Bcl-2 in alpha beta T cell development in mice deficient in the common cytokine receptor γ-chain: the requirement for Bcl-2 differs depending on the TCR/MHC affinity. J Immunol. 162:1999;782-790.
63. -/- mice. Cell. 89:1997;1011-1019.
64. Candeias S., Muegge K., Durum S.K. IL-7 receptor and VDJ recombination: trophic versus mechanistic actions. Immunity. 6:1997;501-508.
65. Corcoran A.E., Riddell A., Krooshoop D., Venkitaraman A.R. Impaired immunoglobulin gene rearrangement in mice lacking the IL-7 receptor. Nature. 391:1998;904-907.
66. Malissen M., Pereira P., Gerber D.J., Malissen B., DiSanto J.P. The common cytokine receptor γ chain controls survival of γ/δ T cells. J Exp Med. 186:1997;1277-1285.
67. Durum S.K., Candeias S., Nakajima H., Leonard W.J., Baird A.M., Berg L.J., Muegge K. Interleukin 7 receptor control of T cell receptor γ gene rearrangement: role of receptor-associated chains and locus accessibility. J Exp Med. 188:1998;2233-2241.
68. Lodolce J.P., Boone D.L., Chai S., Swain R.E., Dassopoulos T., Trettin S., Ma A. IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation. Immunity. 9:1998;669-676.
69. Di Santo J.P., Rodewald H.R. In vivo roles of receptor tyrosine kinases and cytokine receptors in early thymocyte development. Curr Opin Immunol. 10:1998;196-207.
70. Di Santo J.P. Inherited cytokine and cytokine receptor deficiencies in man. Int Rev Immunol. 17:1998;103-120.
71. Fischer A., Malissen B. Natural and engineered disorders of lymphocyte development. Science. 280:1998;237-243.
72. Kung C., Pingel J.T., Heikinheimo M., Klemola T., Varkila K., Yoo L.I., Vuopala K., Poyhonen M., Uhari M., Rogers M.et al. Mutations in the tyrosine phosphatase CD45 gene in a child with severe combined immunodeficiency disease. Nat Med. 6:2000;343-345.